Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?

References

• Boersma WG, Erjavec Z, van der Werf TS, de Vries-Hosper HG, Gouw ASH, Manson WL. Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL. Respir Med. 2007;101:317–25.
   PubMed Web of Science ®Google Scholar
• Baskova L, Buchta V. Laboratory diagnostics of invasive fungal infections: an overview with emphasis on molecular approach. Folia Microbiol (Praha). 2012;57:421–30.
   PubMed Web of Science ®Google Scholar
• Forslow U, Remberger M, Nordlander A, Mattsson J. The clinical importance of bronchoalveolar lavage in allogeneic SCT patients with pneumonia. Bone Marrow Transplant. 2010;45:945–50.
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Zollner-Schwetz I, Sill H, Linkesch W, Lass-Florl C, Schnedl WJ, et al. Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies. Mycoses. 2011;54:454–9.
   PubMed Web of Science ®Google Scholar
• Ramila E, Sureda A, Martino R, Santamaria A, Franquet T, Puzo C, et al. Bronchoscopy guided by high-resolution computed tomography for the diagnosis of pulmonary infections in patients with hematologic malignancies and normal plain chest X-ray. Haematologica. 2000;85:961–6.
   PubMed Web of Science ®Google Scholar
• Cordani S, Manna A, Vignali M, Tascini C. Bronchoalveolar lavage as a diagnostic tool in patients with hematological malignancies and pneumonia. Infez Med. 2008;16:209–13.
   PubMedGoogle Scholar
• Hummel M, Rudert S, Hof H, Hehlmann R, Buchheidt D. Diagnostic yield of bronchoscopy with bronchoalveolar lavage in febrile patients with hematologic malignancies and pulmonary infiltrates. Ann Hematol. 2008;87:291–7.
   PubMed Web of Science ®Google Scholar
• Maschmeyer G, Carratalà J, Buchheidt D, Hamprecht A, Heussel CP, Kahl C, et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol. 2015;26:21–33.
   PubMed Web of Science ®Google Scholar
• Shannon VR, Andersson BS, Lei X, Champlin RE, Kontoyiannis DP. Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2010;45:647–55.
   PubMed Web of Science ®Google Scholar
• Kuehnhardt D, Hannemann M, Schmidt B, Heider U, Possinger K, Eucker J. Therapeutic implication of BAL in patients with neutropenia. Ann Hematol. 2009;88:1249–56.
   PubMed Web of Science ®Google Scholar
• Hohenadel IA, Kiworr M, Genitsariotis R, Zeidler D, Lorenz J. Role of bronchoalveolar lavage in immunocompromised patients with pneumonia treated with a broad spectrum antibiotic and antifungal regimen. Thorax. 2001;56:115–20.
   PubMed Web of Science ®Google Scholar
• Seneviratna A, O'Carroll M, Lewis CA, Milne D. Diagnostic yield of bronchoscopic sampling in febrile neutropenic patients with pulmonary infiltrate and haematological disorders. Intern Med J. 2012;42:536–41.
   PubMed Web of Science ®Google Scholar
• Elston WJ, Whittaker AJ, Khan LN, Flood-Page P, Ramsay C, Jeffery PK, et al. Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma. Eur Respir J. 2004;24:375–7.
   PubMed Web of Science ®Google Scholar
• Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis. 2007;44:373–9.
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–21.
   PubMed Web of Science ®Google Scholar
• Klastersky J, Paesmans M. The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients. Support Care Cancer. 2013;21:1487–95.
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:e56–93.
   PubMed Web of Science ®Google Scholar
• Buchheidt D. Molecular diagnosis of invasive aspergillosis in patients with hematologic malignancies – new answers to a diagnostic challenge? Expert Opin Med Diagn. 2008;2:753–61.
   PubMedGoogle Scholar
• Hoenigl M, Prattes J, Spiess B, Wagner J, Prueller F, Raggam RB, et al. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2014;52:2039–45.
   PubMed Web of Science ®Google Scholar
• Fillatre P, Decaux O, Jouneau S, Revest M, Gacouin A, Robert-Gangneux F, et al. Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients. Am J Med.2014;127:1242.e11–17.
   PubMed Web of Science ®Google Scholar
• Luong M-L, Filion C, Labbé A-C, Roy J, Pépin J, Cadrin-Tourigny J, et al. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies. Diagn Microbiol Infect Dis. 2010;68:132–9.
   PubMed Web of Science ®Google Scholar
• Buchheidt D, Spiess B, Hofmann W-K, Reinwald M. Galactomannan-based and PCR-based assays in bronchoalveolar lavage to diagnose invasive aspergillosis: current status and future prospects. Curr Fungal Infect Rep. 2013;7:273–82.
   Google Scholar
• Onishi A, Sugiyama D, Kogata Y, Saegusa J, Sugimoto T, Kawano S, et al. Diagnostic accuracy of serum 1,3-β-d-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol. 2012;50:7–15.
   PubMed Web of Science ®Google Scholar
• Morrissey CO, Gilroy NM, Macesic N, Walker P, Ananda-Rajah M, May M, et al. Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014. Intern Med J. 2014;44:1298–314.
   PubMed Web of Science ®Google Scholar